HLA-II antagonist (CIGB)

N/A

Report date: 2025/02/01 20:00:06

Base Information

Drug NameHLA-II antagonist (CIGB)
Drug Alias NameN/A
ClassificationBiologics > Protein drugs > Recombinant polypeptide
Mechanisms of ActionHistocompatibility antigens class II inhibitors
TargetsHistocompatibility antigens class II
Therapy Area/IndicationsAutoimmune DiseasesArthritis, Juvenile
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryCuba
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesCenter For Genetic Engineering And Biotechnology
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesCenter For Genetic Engineering And Biotechnology
Active IndicationsN/A
Inactive IndicationsAutoimmune DiseasesArthritis, Juvenile

Other Information

ATC CodeN/A
Related LinksN/A